Grete Hogstad
Corporate Officer/Principal at Association for Accessible Medicines
Net worth: 170 509 $ as of 2024-06-29
Profile
Grete Hogstad is currently a Member at the Association for Accessible Medicines.
Previously, she held positions as a Director at Navamedic ASA, Alpharma, Inc., and Xellia Pharmaceuticals AS.
From 2005 to 2023, she served as the VP-Strategic Marketing & Business Development at Photocure ASA. Ms. Hogstad has an undergraduate degree from the University of Oslo and BI Norwegian Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHOTOCURE ASA
0.11% | 2022-12-30 | 30,719 ( 0.11% ) | 170 509 $ | 2024-06-29 |
Grete Hogstad active positions
| Companies | Position | Start |
|---|---|---|
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Corporate Officer/Principal | - |
Former positions of Grete Hogstad
| Companies | Position | End |
|---|---|---|
| PHOTOCURE ASA | Sales & Marketing | 2023-06-30 |
| Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Sales & Marketing | - |
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Sales & Marketing | - |
| NAVAMEDIC ASA | Director/Board Member | - |
Training of Grete Hogstad
| University of Oslo | Undergraduate Degree |
| BI Norwegian Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| NAVAMEDIC ASA | Distribution Services |
| Private companies | 3 |
|---|---|
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
| Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Health Technology |
- Stock Market
- Insiders
- Grete Hogstad
